Company: PHAT
Filing Date: 2025-04-23
Form Type: DEFA14A
Source: 0000950170-25-057335
Chunk: 1

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEFA14A
Chunk 1
---
 will not otherwise receive a paper or email copy.For complete information and to vote, visit www.ProxyVote.com Control #Vote Virtually at the Meeting*June 3, 202511:30 AM EDT Smartphone users Point your camera here and vote without entering a control number Virtually at:www.virtualshareholdermeeting.com/PHAT2025*Please check the meeting materials for any special requirements for meeting attendance.

Vote at www.ProxyVote.com Board Recommends Voting Items1. To elect two class III directors to hold office until the 2028 Annual Meeting of Stockholders. Nominees: 1a. Heidi Kunz For 1b. James Topper, M.D., Ph.D. For 2. To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. For 3. To approve the compensation of the named executive officers on a non-binding advisory basis (“say-on-pay”). For 4. To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers (“say-on-frequency”).1YearNOTE: Such other business as may properly come before the meeting or any adjournment thereof. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.